First Trust Advisors LP Biogen Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Biogen Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 358,491 shares of BIIB stock, worth $56.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

358,491

Previous 389,951 8.07%

Holding current value

$56.6 Million

Previous $90.4 Million 23.13%

% of portfolio

0.07%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $5.95 Million - $7.45 Million	-31,460 Reduced 8.07%	358,491 $69.5 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $10.6 Million - $13.2 Million	55,655 Added 16.65%	389,951 $90.4 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $136 Million - $172 Million	-643,012 Reduced 65.79%	334,296 $72.1 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $127 Million - $153 Million	571,795 Added 141.01%	977,308 $253 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $1.57 Million - $1.77 Million	-6,186 Reduced 1.5%	405,513 $104 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $7.19 Million - $8.3 Million	26,107 Added 6.77%	411,699 $117 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $28.3 Million - $32.2 Million	110,309 Added 40.07%	385,592 $107 Million
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $28.7 Million - $34.9 Million	-113,693 Reduced 29.23%	275,283 $76.2 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $9.82 Million - $13.5 Million	-50,425 Reduced 11.48%	388,976 $104 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $7.85 Million - $9.34 Million	41,880 Added 10.54%	439,401 $89.6 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $10.1 Million - $12.7 Million	52,172 Added 15.11%	397,521 $83.7 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $3.7 Million - $4.76 Million	16,541 Added 5.03%	345,349 $82.9 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $29.2 Million - $38.1 Million	-103,298 Reduced 23.91%	328,808 $93 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $2.71 Million - $4.33 Million	10,447 Added 2.48%	432,106 $150 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $2.05 Million - $2.4 Million	8,441 Added 2.04%	421,659 $118 Million
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $4.78 Million - $7.19 Million	-20,223 Reduced 4.67%	413,218 $101 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $9.47 Million - $10.9 Million	35,775 Added 9.0%	433,441 $123 Million
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $21.4 Million - $28.4 Million	-82,922 Reduced 17.25%	397,666 $106 Million
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $16.6 Million - $21.1 Million	-61,835 Reduced 11.4%	480,588 $152 Million
Q4 2019 Feb 03, 2020	BUY	$220.06 - $304.07 $26.1 Million - $36 Million	118,511 Added 27.96%	542,423 $161 Million
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $33.6 Million - $37.7 Million	-154,494 Reduced 26.71%	423,912 $98.7 Million
Q2 2019 Jul 30, 2019	BUY	$219.29 - $241.72 $37.7 Million - $41.5 Million	171,855 Added 42.27%	578,406 $135 Million
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $5.36 Million - $8.38 Million	24,735 Added 6.48%	406,551 $96.1 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $11.2 Million - $14.2 Million	40,357 Added 11.82%	381,816 $115 Million
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $25.1 Million - $32.8 Million	85,505 Added 33.41%	341,459 $121 Million
Q2 2018 Aug 02, 2018	BUY	$257.52 - $306.91 $5.31 Million - $6.32 Million	20,608 Added 8.76%	255,954 $74.3 Million
Q1 2018 Apr 23, 2018	BUY	$260.13 - $367.91 $6.76 Million - $9.57 Million	26,001 Added 12.42%	235,346 $64.4 Million
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $3.94 Million - $4.42 Million	-12,815 Reduced 5.77%	209,345 $66.7 Million
Q3 2017 Oct 24, 2017	BUY	$281.15 - $329.69 $62.5 Million - $73.2 Million	222,160	222,160 $69.6 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Biogen Inc. Transaction History